Figure 5.
Identification and validation of potential therapeutic compounds. (A) The description of top 10 promising small molecules for IBD treatment. (B) The chemical structure of the top-ranked BMS-536924. (C) The cytotoxicity of BMS-536924 on HT29 cells by CCK8 assay. The effects of BMS-536924 treatment on the expression of proinflammatory cytokines (D) IL-6 and (E) TNF-α in LPS-induced HT29 cells. Values are expressed as the means ± SD; n = 4 in each group. ### p < 0.001 vs. the NC group. ** p < 0.01, *** p < 0.001, and **** p < 0.0001 vs. the LPS group.